Valuation: Orion Oyj

Market Cap 9.56B 10.93B 8.83B 8.16B 15.37B 1,050B 15.65B 105B 41.33B 514B 41.07B 40.16B 1,771B P/E 2026 *
17.4x
P/E 2027 * 14.7x
Enterprise Value 9.45B 10.82B 8.74B 8.08B 15.21B 1,039B 15.48B 104B 40.9B 509B 40.64B 39.74B 1,752B EV / Sales 2026 *
4.54x
EV / Sales 2027 * 3.93x
Free-Float
90.5%
Yield 2026 *
2.81%
Yield 2027 * 3.11%
1 day+0.52%
1 week-3.11%
Current month-4.79%
1 month+2.85%
3 months-6.23%
6 months-1.79%
Current year+7.62%
1 week 67.2
Extreme 67.2
71
1 month 66.1
Extreme 66.1
72.75
Current year 62.7
Extreme 62.7
75.3
1 year 56.5
Extreme 56.5
75.3
3 years 31.86
Extreme 31.86
75.3
5 years 31.86
Extreme 31.86
75.3
10 years 22.57
Extreme 22.57
75.3
Manager TitleAgeSince
Chief Executive Officer 59 01/11/2022
Director of Finance/CFO 50 01/05/2024
Chief Operating Officer 46 01/01/2022
Director TitleAgeSince
Director/Board Member 63 22/03/2017
Director/Board Member 65 22/03/2017
Director/Board Member 66 06/05/2020
Date Insider Type Main position Quantity % Market Cap.
08/08/25Sell

Chief Operating Officer

4,000 0.0122%
04/08/25Sell

Executive/Senior Manager

605 0.0018%
04/08/25Sell

Executive/Senior Manager

724 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
+0.88%-3.11%+3.87%+107.58% 10.93B
-0.92%-5.92%+48.22%+155.83% 1,028B
-1.16%-4.83%+61.55%+57.58% 611B
+1.70%-2.16%+32.67%+83.40% 432B
+0.98%-1.40%+29.49%+23.12% 323B
-0.34%-3.10%+27.00%+43.66% 277B
+1.63%-11.76%+19.72%+23.20% 257B
+3.39%+2.29%-23.68%-38.33% 217B
+1.24%-2.39%+22.79%+57.65% 192B
+2.11%-2.51%+21.41%+70.90% 161B
Average +0.96%-5.27%+24.30%+58.46% 350.93B
Weighted average by Cap. +0.34%-5.52%+35.94%+77.60%

Financials

2026 *2027 *
Net sales 2.08B 2.38B 1.92B 1.78B 3.35B 229B 3.41B 22.94B 9B 112B 8.94B 8.75B 386B 2.35B 2.69B 2.18B 2.01B 3.79B 259B 3.85B 25.95B 10.18B 127B 10.12B 9.89B 436B
Net income 550M 629M 508M 469M 884M 60.4B 900M 6.06B 2.38B 29.58B 2.36B 2.31B 102B 649M 743M 600M 554M 1.04B 71.35B 1.06B 7.16B 2.81B 34.94B 2.79B 2.73B 120B
Net Debt -100M -115M -92.81M -85.75M -161M -11.04B -164M -1.11B -434M -5.4B -432M -422M -18.61B -312M -356M -288M -266M -501M -34.24B -510M -3.43B -1.35B -16.77B -1.34B -1.31B -57.73B
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,132
Date Price Change Volume
15/07/26 68.50 +0.88% 174,529
14/07/26 €67.90 -1.59% 122,785
13/07/26 €69.00 -0.93% 132,473
10/07/26 €69.65 -1.28% 108,328
09/07/26 €70.55 -0.21% 139,236
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
67.90EUR
Average target price
74.33EUR
Spread / Average Target
+9.47%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ORNBV Stock